Webinars on demand

In this webinar, we’ll introduce two European laboratories, which did not use next generation sequencing (NGS) prior to implementing Ion Torrent™ Genexus™ System.

In this webinar, we will review current guidelines and recommendations for MSI testing in solid tumors.

For patients with acute myeloid leukemia (AML) treated with chemotherapy, the contribution of genetic heterogeneity to drug resistance and disease progression has been well-established.

The relevance to understand the entire tumor heterogeneity, its immune environment and contextual relationship requires the spatial quantification of different immune and tumor cells.

The demand for access to less invasive biopsy methods for cancer presents a critical decision for many provider laboratories.

Want to learn how to achieve IHC assays in 30 minutes and multiplex assays in 2.5 hours?

Understanding the complex spatial distribution of key immune cell populations in tumors is the next frontier in advancing our understanding of cancer to inform the development of novel therapeutics.

Come hear the latest on clinical-grade AI workflows from Paige.

The latest thinking in the area of color fidelity in digital pathology.

The relevance to understand the entire tumor heterogeneity, its immune environment and contextual relationship requires the spatial quantification of different immune and tumor cells...

Dr Filippo Fraggetta shares his experience and clinical results of using INIFY Prostate Screening in the fully digitalized workflow at Cannizzaro hospital, Catania, Italy.

In this webinar, Dr. Frances High will explore how she used Bionano’s Saphyr system for optical genome mapping to analyze structural variations in a large cohort of patients with CDH and their parents.